肿瘤栓塞物质的全球市场
市场调查报告书
商品编码
1132246

肿瘤栓塞物质的全球市场

Oncology Embolization Agents Market

出版日期: | 出版商: Life Science Intelligence | 英文 9 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

肿瘤栓塞物质,用于封闭病灶和肿瘤血管,靶向营养物质,增强药物靶向递送的有效性,并诱导细胞死亡。

本报告提供全球肿瘤栓塞物质市场相关调查,放射线栓塞,化学栓塞,粒子栓塞等的肿瘤栓塞物质相关以下主要的分析。

  • 数量(2020年~2026年)
  • 市场预测(2020年~2026年)
  • 主要的竞争形势分析
  • 策略与Start-Ups的主要市场活动相关洞察
简介目录
Product Code: LSI-07252022-OncologyEmbolizationAgents

This report from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.

This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups